Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks

Source The Motley Fool

Generating thousands of dollars of recurring income can be a great way to make you less reliant on employment income or retirement benefits. If you have savings that you can afford to invest in stocks, there are multiple high-yielding dividend investments to consider right now. While many investors have been focusing on growth stocks and hype surrounding artificial intelligence, dividend stocks have been on the back burner of late, which could make now an advantageous time to invest in them.

Three dividend stocks that can be excellent options for the long term are Bristol Myers Squibb (NYSE: BMY), Kraft Heinz (NASDAQ: KHC), and Enbridge (NYSE: ENB). By investing $20,000 into each of these stocks, you can potentially earn more than $3,000 in annual dividends.

1. Bristol Myers Squibb

Healthcare giant Bristol Myers Squibb pays a dividend that yields 4.3% -- far higher than the S&P 500 average of just 1.2%. If you invest $20,000 into the stock, that will generate approximately $860 in dividends over the course of a full year.

Investors have been concerned about the company's many patent cliffs involving its top drugs. But the stock trades at a heavily discounted 8 times its estimated future earnings, and the company has recently been accumulating approvals for new drugs (such as Cobenfy and Breyanzi) and bolstering its long-term growth prospects. So it may be an overblown situation at this point, making Bristol Myers Squibb a potentially undervalued dividend stock to buy and hold. Many drugs in the company's "growth portfolio" have generated growth in excess of 30% through the first nine months of the year.

Bristol Myers Squibb has generated free cash flow of more than $13.8 billion over the trailing 12 months, which is more than enough to cover its cash dividend payments totaling $4.8 billion during that time frame. Over the long haul, this is a dividend stock I'd feel comfortable holding on to, given the company's track record for continuous innovation and drug development.

2. Kraft Heinz

Another underrated dividend stock to hold today is Kraft Heinz. Strong brands and fairly stable earnings make this an ideal dividend investment to buy and hold. At 5.1%, its yield is higher than Bristol Myers Squibb's, and it can generate even more income for you -- $1,020 based on a $20,000 investment.

While Kraft Heinz has encountered some choppiness in its earnings of late due to nonrecurring impairment charges, its overall cash flow looks solid. The company pays around $480 million in cash dividends per quarter and normally generates more than that in free cash flow, which suggests that the payout is in no danger. In the trailing 12 months, Kraft Heinz's free cash flow has totaled $3 billion, versus $1.9 billion in cash dividends paid.

Kraft Heinz isn't much of a growth stock these days, but it has been stable. It has generated at least $26 billion in revenue in each of the past four years, and its operating income has been north of $5 billion in three of those years. If your priority is a good dividend stock, Kraft Heinz should be a top option to consider.

3. Enbridge

The highest-yielding dividend on this list belongs to Enbridge, whose payout tops 6.2%. Investing $20,000 in the stock would put you on a path to collecting roughly $1,240 per year in dividends. When adding that to the other stocks listed here, your total annual dividend income from these three investments would total approximately $3,140. Enbridge has also been increasing its dividend payment for 29 straight years, making it probable that your recurring income will also rise over the long haul.

The Canada-based pipeline company recently completed acquisitions of multiple U.S. natural gas utilities, which will bolster its long-term growth prospects. Management says these utilities "are a perfect fit within Enbridge's existing low-risk business model, offer reliable cash flow, and come with embedded quick-cycle growth opportunities."

Enbridge is a good, stable stock to own. It says it should finish at the high end of the guidance it provided for the year for earnings before interest, taxes, depreciation, and amortization (EBITDA), and its distributable cash flow numbers (which it uses to evaluate its dividend) are in line with last year's performance. This is one of the safer oil and gas stocks to buy and hold.

Should you invest $1,000 in Bristol Myers Squibb right now?

Before you buy stock in Bristol Myers Squibb, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bristol Myers Squibb wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $900,893!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of November 18, 2024

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bristol Myers Squibb and Enbridge. The Motley Fool recommends Kraft Heinz. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Understanding the first crypto market crash of 2024 and what to expect nextThe 365-day MVRV ratio suggests that this crash may be just the beginning. If the ETF is rejected before the second quarter of 2024, it could trigger a sharp correction.
Author  FXStreet
Jan 04, Thu
The 365-day MVRV ratio suggests that this crash may be just the beginning. If the ETF is rejected before the second quarter of 2024, it could trigger a sharp correction.
placeholder
Japanese Yen stands tall near one-month top against USD on hawkish BoJ talksThe Japanese Yen (JPY) rallied to the highest level since early February against its American counterpart on Friday amid bets for an imminent shift in the Bank of Japan's (BoJ) policy stance.
Author  FXStreet
Mar 11, Mon
The Japanese Yen (JPY) rallied to the highest level since early February against its American counterpart on Friday amid bets for an imminent shift in the Bank of Japan's (BoJ) policy stance.
placeholder
Natural Gas sinks to pivotal level as China’s demand slumpsNatural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
Author  FXStreet
Jul 01, Mon
Natural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
placeholder
Is It Too Late to Buy MicroStrategy Stock?Bitcoin is soaring again. The cryptocurrency's price recently passed $90,000 to a new all-time high. It's up by close to 1,000% in the last five years. That has to make MicroStrategy (NASDAQ: MSTR) and its ex-CEO, Michael Saylor, happy.
Author  The Motley Fool
Nov 18, Mon
Bitcoin is soaring again. The cryptocurrency's price recently passed $90,000 to a new all-time high. It's up by close to 1,000% in the last five years. That has to make MicroStrategy (NASDAQ: MSTR) and its ex-CEO, Michael Saylor, happy.
placeholder
Pinduoduo Earnings Incoming: Morgan Stanley Sees Long-Term Profit Potential​Insights – On November 21, Chinese e-commerce giant Pinduoduo (PDD) will release its Q3 2024 earnings.
Author  Mitrade
Yesterday 08: 44
​Insights – On November 21, Chinese e-commerce giant Pinduoduo (PDD) will release its Q3 2024 earnings.
goTop
quote